List view / Grid view
4 March 2014 | By Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd. announces the approval of the generic equivalent to Evista® (Raloxifene) Tablets, 60 mg...
4 March 2014 | By The European Medicines Agency
The European Medicines Agency reminds applicants and marketing-authorisation holders that adjusted fees will be coming into effect on Tuesday 1 April 2014...
4 March 2014 | By Artel
Artel, the leader in liquid handling quality assurance, announced that it has acquired exclusive rights to the LabGauge product line from Louisville, Kentucky-based StackWave...
4 March 2014 | By Malvern Instruments
Malvern Instruments brings a new addition to Pittcon in 2014, exhibiting NanoSight Nanoparticle Tracking Analysis systems within its growing portfolio of analytical solutions for industry and academia...
4 March 2014 | By Waters
Enhanced MS with the turn of a key...
4 March 2014 | By Malvern Instruments
Recent addition to Malvern’s chromatography range offers a new choice of GPC/SEC light scattering detector...
4 March 2014 | By Renishaw
Renishaw’s new StreamLineHR™ Rapide option for its inVia Raman microscope enables the rapid collection of large amounts of Raman data...
4 March 2014 | By Waters
Scientists attending Pittcon get first-hand look at mass detector...
B&W Tek, Inc., an advanced instrumentation company that delivers lab quality Raman spectroscopy solutions through user-friendly mobile platforms, is pleased to announce its newest strategic partnership with LabWare, Inc., the global leader of Laboratory Information Management Systems (LIMS) and instrument integration software products.
3 March 2014 | By Roche
Roche announced that an independent data monitoring committee has recommended that the phase III METLung study be stopped due to a lack of clinically meaningful efficacy...
3 March 2014 | By Teva
The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults...
3 March 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities...
3 March 2014 | By AstraZeneca
AstraZeneca announced that the US Food and Drug Administration has approved the BYDUREON® Pen 2 mg as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes...
3 March 2014 | By Renishaw
Renishaw’s Raman spectroscopy team will be hosting its next Inside Raman seminar on Tuesday 8th and Wednesday 9th April 2014...
28 February 2014 | By Novartis
Novartis joins the global rare disease community in recognition of Rare Disease Day by calling for a global exchange of ideas to deepen the understanding of rare diseases and help address a significant unmet medical need...
